Neda A. Moatamed

ORCID: 0000-0002-9986-8058 · 5 papers in corpus
2025
·doi:10.1093/ajcp/aqaf121.195

Abstract Introduction/Objective Physiologic changes in the gynecologic tract of transmasculine individuals have been reported in the literature. However, reports of gynecologic pathology in transmasculine individuals are limited. In this ca…

case-report 2023
Gynecologic oncology reports ·doi:10.1016/j.gore.2023.101192

Squamous cell carcinoma of the ovary (SCC) is a rare and aggressive disease and optimal treatment is unknown. Here we report the case of a 29- year-old woman who presented with abdominal pain and was ultimately found to have a multi-septate…

other 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00175-w

Progesterone therapy is a viable treatment for complex atypical hyperplasia (CAH) and endometrial adenocarcinoma, though reliable molecular determinants of response are not available. To explore if analysis of pre-therapy endometrial biopsi…

observational 2020
PloS one ·doi:10.1371/journal.pone.0242772

BACKGROUND: In recent years, sentinel lymph node excision and ultrastaging have been performed in endometrial carcinomas to obtain information about lymph node status, avoiding unnecessary complete pelvic and paraaortic lymphadenectomy. The…

case-report 2018
Case reports in pathology ·doi:10.1155/2018/8148147

BACKGROUND: BRCA gene mutations significantly increase the risk of breast and ovarian cancers where the lifetime risk of the ovarian cancer is about 40%. Therefore, many women with such mutations undergo prophylactic bilateral mastectomy an…